These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16092430)

  • 1. Bioavailability of indomethacin in liposomes.
    Stozek T
    Acta Pol Pharm; 1992; 49(4):21-6. PubMed ID: 16092430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule based proliposomes.
    Katare OP; Vyas SP; Dixit VK
    J Microencapsul; 1995; 12(5):487-93. PubMed ID: 8544092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic and pharmacodynamic profile of the trioxyethylene ester of indomethacin in a new oral prodrug].
    Palagiano F; de Caprariis P; Bonina FP; Montenegro L; Capasso A; Sorrentino L
    Boll Chim Farm; 1996 Feb; 135(2):89-91. PubMed ID: 9044565
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules.
    Cattani VB; Pohlmann AR; Dalla Costa T
    Int J Pharm; 2008 Nov; 363(1-2):214-6. PubMed ID: 18678236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability studies on fast release formulations of indomethacin.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2002; 141(3):176-80. PubMed ID: 12197414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bioavailability and tolerance of indomethacin as polymeric mini-capsules in man].
    Maboundou CW; Paintaud G; Ottignon Y; Magnette J; Bechtel Y; Fessi H; Gouchet F; Carayon P; Bechtel P
    Therapie; 1996; 51(1):88-9. PubMed ID: 8762227
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
    Kim JY; Ku YS
    Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The increase of bioavailability and anti-inflammatory effect of indomethacin loaded into phospholipid nanoparticles].
    Shironin AV; Ipatova OM; Medvedeva NV; Prozorovskiĭ VN; Tikhonova EG; Zakharova TS; Sanzhakov MA; Torkhovskaia TI
    Biomed Khim; 2011; 57(6):671-6. PubMed ID: 22359924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of indomethacin nanocapsules.
    Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S
    Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-core nanocapsules restrained the indomethacin ethyl ester hydrolysis in the gastrointestinal lumen and wall acting as mucoadhesive reservoirs.
    Cattani VB; Fiel LA; Jäger A; Jäger E; Colomé LM; Uchoa F; Stefani V; Dalla Costa T; Guterres SS; Pohlmann AR
    Eur J Pharm Sci; 2010 Jan; 39(1-3):116-24. PubMed ID: 19932749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin-loaded redox nanoparticles improve oral bioavailability of indomethacin and suppress its small intestinal inflammation.
    Yoshitomi T; Sha S; Vong LB; Chonpathompikunlert P; Matsui H; Nagasaki Y
    Ther Deliv; 2014 Jan; 5(1):29-38. PubMed ID: 24341815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of indomethacin in poultry.
    Cristòfol C; Valladares JE; Martí G; Arboix M
    Avian Dis; 2000; 44(1):210-4. PubMed ID: 10737665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
    Simovic S; Hui H; Song Y; Davey AK; Rades T; Prestidge CA
    J Control Release; 2010 May; 143(3):367-73. PubMed ID: 20079390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliposomes of indomethacin for oral administration.
    Katare OP; Vyas SP; Dixit VK
    J Microencapsul; 1991; 8(1):1-7. PubMed ID: 1880686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin release in relation to the concentration of pharmaceutical excipients.
    Potúcková M; Vitková Z; Tichý E; Simunková V
    Pharmazie; 2008 Jun; 63(6):485-6. PubMed ID: 18604995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study.
    Srinath P; Chary MG; Vyas SP; Diwan PV
    Pharm Acta Helv; 2000 Apr; 74(4):399-404. PubMed ID: 10812940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of acute uraemia on percutaneous absorption of nonsteroidal anti-inflammatory drugs.
    Príborský J; Takayama K; Nagai T
    Acta Univ Palacki Olomuc Fac Med; 1998; 141():35-8. PubMed ID: 9684479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of acemetacin and its active metabolite indomethacin in rats during acute hepatic damage and liver regeneration.
    Chávez-Piña AE; Favari L; Castañeda-Hernández G
    Ann Hepatol; 2009; 8(2):141-7. PubMed ID: 19502658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of submicronized chitosan-coated liposomes in oral absorption of indomethacin.
    Sugihara H; Yamamoto H; Kawashima Y; Takeuchi H
    J Liposome Res; 2012 Mar; 22(1):72-9. PubMed ID: 22329417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of indomethacin amphoteric gel on gastric ulcerogenicity and absorption of indomethacin in rats.
    Liversidge GG; Dent J; Eickhoff WM
    Pharm Res; 1989 Jan; 6(1):44-8. PubMed ID: 2717517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.